|
85
|
307
|
4bdiA |
Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (chk2) |
|
85
|
303
|
4bdjA |
Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (chk2) |
|
78
|
293
|
4bc6A |
Crystal structure of human serine threonine kinase-10 bound to novel bosutinib isoform 1, previously thought to be bosutinib |
|
95
|
350
|
4b7tA |
Glycogen synthase kinase 3 beta complexed with axin peptide and leucettine l4 |
|
76
|
266
|
4b0gA |
Complex of aurora-a bound to an imidazopyridine-based inhibitor |
|
77
|
293
|
4aw1A |
Human pdk1 kinase domain in complex with allosteric compound ps210 bound to the pif-pocket |
|
95
|
330
|
4bfmA |
The crystal structure of mouse pk38 |
|
86
|
304
|
4bdaA |
Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (chk2) |
|
79
|
285
|
4aw0A |
Human pdk1 kinase domain in complex with allosteric compound ps182 bound to the pif-pocket |
|
87
|
303
|
4bdhA |
Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (chk2) |
|
89
|
304
|
4bdgA |
Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (chk2) |
|
282
|
947
|
3zw3A |
Fragment based discovery of a novel and selective pi3 kinase inhibitor |
|
107
|
349
|
4afjA |
5-aryl-4-carboxamide-1,3-oxazoles: potent and selective gsk-3 inhibitors |
|
77
|
277
|
4a4xA |
Nek2-ede bound to cct248662 |
|
90
|
310
|
3zuuA |
The structure of ost1 (d160a, s175d) kinase in complex with gold |
|
104
|
349
|
3zrkA |
Identification of 2-(4-pyridyl)thienopyridinones as gsk-3beta inhibitors |
|
96
|
292
|
4appA |
Crystal structure of the human p21-activated kinase 4 in complex with (s)-n-(5-(3-benzyl-1-methylpiperazine-4-carbonyl)-6,6-dimethyl-1,4,5, 6-tetrahydropyrrolo(3,4-c)pyrazol-3-yl)-3-phenoxybenzamide |
|
95
|
350
|
4achA |
Gsk3b in complex with inhibitor |
|
93
|
302
|
4a9sA |
Crystal structure of human chk2 in complex with benzimidazole carboxamide inhibitor |
|
72
|
270
|
3zxtA |
Dimeric structure of dapk-1 catalytic domain in complex with amppcp- mg |
|
107
|
349
|
3zrlA |
Identification of 2-(4-pyridyl)thienopyridinones as gsk-3beta inhibitors |
|
99
|
303
|
4apcA |
Crystal structure of human nima-related kinase 1 (nek1) |
|
62
|
146
|
4a1gA |
The crystal structure of the human bub1 tpr domain in complex with the ki motif of knl1 |
|
88
|
270
|
3ztxA |
Aurora kinase selective inhibitors identified using a taxol-induced checkpoint sensitivity screen. |
|
113
|
328
|
4anmA |
Complex of ck2 with a cdc7 inhibitor |
|
74
|
277
|
4afeA |
Nek2 bound to hybrid compound 21 |
|
77
|
284
|
4a07A |
Human pdk1 kinase domain in complex with allosteric activator ps171 bound to the pif-pocket |
|
103
|
348
|
3zrmA |
Identification of 2-(4-pyridyl)thienopyridinones as gsk-3beta inhibitors |
|
98
|
350
|
4accA |
Gsk3b in complex with inhibitor |
|
91
|
304
|
4a9tA |
Crystal structure of human chk2 in complex with benzimidazole carboxamide inhibitor |
|
82
|
283
|
4a06A |
Human pdk1 kinase domain in complex with allosteric activator ps114 bound to the pif-pocket |
|
89
|
310
|
3zutA |
The structure of ost1 (d160a) kinase |
|
80
|
273
|
4alwA |
Benzofuropyrimidinone inhibitors of pim-1 |
|
89
|
303
|
4a9rA |
Crystal structure of human chk2 in complex with benzimidazole carboxamide inhibitor |
|
90
|
304
|
4a9uA |
Crystal structure of human chk2 in complex with benzimidazole carboxamide inhibitor |
|
81
|
274
|
4alvA |
Benzofuropyrimidinone inhibitors of pim-1 |
|
74
|
269
|
4af3A |
Human aurora b kinase in complex with incenp and vx-680 |
|
101
|
350
|
4acdA |
Gsk3b in complex with inhibitor |
|
94
|
350
|
4acgA |
Gsk3b in complex with inhibitor |
|
76
|
274
|
4a7cA |
Crystal structure of pim1 kinase with etp46546 |
|
87
|
299
|
4aotA |
Crystal structure of human serine threonine kinase-10 (lok) bound to gw830263a |
|
77
|
274
|
4aluA |
Benzofuropyrimidinone inhibitors of pim-1 |
|
116
|
334
|
3wikA |
Crystal structure of the ck2alpha/compound10 complex |
|
90
|
292
|
3wf7A |
Crystal structure of s6k1 kinase domain in complex with a purine derivative 1-(9h-purin-6-yl)-n-[3-(trifluoromethyl)phenyl]piperidine-4-carboxamide |
|
104
|
331
|
3wilA |
Crystal structure of the ck2alpha/compound3 complex |
|
111
|
326
|
3w8lA |
Crystal structure of human ck2 in complex with inositol hexakisphosphate |
|
0
|
10
|
3zkfB |
Structure of lc8 in complex with nek9 phosphopeptide |
|
118
|
334
|
3wowA |
Crystal structure of human ck2a with amppnp |
|
87
|
290
|
3wf5A |
Crystal structure of s6k1 kinase domain in complex with a pyrazolopyrimidine derivative 4-[4-(1h-benzimidazol-2-yl)piperidin-1-yl]-1h-pyrazolo[3,4-d]pyrimidine |
|
10
|
49
|
3wwsB |
Crystal structure of serine/threonine-protein kinase 3 |
